Thyrocare Technologies Limited — Regulatory Filings 2021

Feb 13, 2021

==> picture [43 x 330] intentionally omitted <==

==> picture [26 x 464] intentionally omitted <==

ocare� Thyr The Tn..tst. The Truth.

February 13, 2021

To,

The National Stock Exchange of India Limited Exchange Plaza Bandra Kurla Complex, Bandra (E), Mumbai - 400 051

BSE Limited Phiroze Jeejeeboy Towers Dalal Street, Mumbai- 400 001

Dear Sir/Madam,

Sub: Disclosure of information under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Con-call.

--o--

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the representatives of following organizations would be having a con-call with us;

i) Mirabilis Investment Trust, at 05.00 P.M. on Monday, February I 5, 2021.

ii) Arisaig Partners, at 03.00 P.M. on Friday, February 19, 2021.

Please note that these are subject to any last minute changes.

Yours Faithfully,

For Thyrocare Technologies Limited,

==> picture [83 x 86] intentionally omitted <==

==> picture [85 x 41] intentionally omitted <==

Ramjee Dorai Company Secretary and Compliance Officer

Thyrocare Technologies Limited

9 0-37/1, TTC MIDC, Turbhe, Navi Mumbai - 400 703, India (9 022- 3090 0000 / 4125 2525 i:.i enquiry@thyrocare.com @) www.thyrocare.com

(CIN: L85110MH2000PLC12S882)